IC
NXTC icon

Ikarian Capital’s NextCure NXTC Stock Holding History

Ikarian Capital’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,392
Closed -$1.51M – 199
2020
Q1 		$1.51M Buy
+3,392
New +$1.81M 0.11% 105

Other funds holding NXTC

SCM
Squadron Capital Management Westmont, Illinois $273M AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Ikarian Capital's NXTC Position: Q1 2026 in Review

Ikarian Capital held its NextCure (NXTC) position steady in Q1 2026 at 238,303 shares worth $2.51M. The position accounts for 0.2% of the portfolio, ranked #86.

Ikarian Capital first reported a position in NXTC in Q3 2020 and has held it in 10 quarters since. The position peaked at $4.54M in Q1 2021. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

  • Ikarian Capital held 238,303 shares of NextCure worth $2.51M as of Q1 2026.
  • Ikarian Capital left its NextCure share count unchanged in Q1 2026.
  • NextCure made up 0.2% of Ikarian Capital's portfolio in Q1 2026, its #86 holding.
  • Ikarian Capital first reported a position in NextCure in Q3 2020 and has held it in 10 quarters since.
  • Ikarian Capital's NextCure position peaked at $4.54M in Q1 2021.
  • 26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.